BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33268608)

  • 41. A Phase II Study of Neoadjuvant Chemotherapy Followed by Extended Field Concurrent Chemoradiotherapy for Para-aortic Lymph Node Positive Cervical Cancer.
    Shimoji Y; Nagai Y; Toita T; Ariga T; Heianna J; Nakasone T; Taira Y; Arakaki Y; Nakamoto T; Ooyama T; Kudaka W; Kaneshima I; Nishihira K; Mekaru K; Aoki Y
    Anticancer Res; 2020 Jun; 40(6):3565-3570. PubMed ID: 32487659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
    Wang R; Tao X; Wu X; Jiang H; Xia H
    J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis.
    Liu X; Wang W; Meng Q; Zhang F; Hu K
    Jpn J Clin Oncol; 2019 Mar; 49(3):263-269. PubMed ID: 30668725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
    Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
    Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma.
    Park TK; Kwon JY; Kim SW; Kim SH; Kim SN; Kim GE
    Int J Clin Oncol; 2004 Apr; 9(2):120-4. PubMed ID: 15108044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. External beam radiotherapy boost versus surgical debulking followed by radiotherapy for the treatment of metastatic lymph nodes in cervical cancer: A systematic review and meta-analysis.
    Bizzarri N; Di Berardino S; Benkortbi K; Balaya V; Gambacorta MA; Macchia G; Boulvain M; Feki A; Mathevet P; Lecuru F; Querleu D; Ferrandina G; Scambia G; Guani B
    Eur J Surg Oncol; 2024 Apr; 50(4):108013. PubMed ID: 38401353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
    Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer?
    Bader AA; Winter R; Moinfar F; Petru E; Pristauz G; Scholz HS; Haas J; Tamussino KF
    Gynecol Oncol; 2006 Oct; 103(1):106-12. PubMed ID: 16564076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case report: Giant lymph node metastases: a new opportunity for cancer radioimmunotherapy?
    Bian Y; Zhang Z; Deng X; Wen Q; Li D
    Front Immunol; 2024; 15():1357601. PubMed ID: 38348039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy.
    Yildirim BA; Guler OC; Kose F; Onal C
    J Obstet Gynaecol; 2019 Jul; 39(5):695-701. PubMed ID: 31023114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].
    Zhang HY; Sheng XG; Zhong Y; Ma ZF; Ma YB; Liu NF; Chen YT; Wang YY
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):452-5. PubMed ID: 19024522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Ito K; Tsutui T; Ogata T; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Sep; 23(7):1279-86. PubMed ID: 23835505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.
    Zhong ML; Wang YN; Liang MR; Liu H; Zeng SY
    Int J Gynecol Cancer; 2020 May; 30(5):602-606. PubMed ID: 32156715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does debulking of enlarged positive lymph nodes improve survival in different gynaecological cancers?
    Somashekhar SP
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):870-83. PubMed ID: 26043964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Escalated radiation and prophylactic extended field nodal irradiation are beneficial for FIGO IIIB cervical cancer patients' prognosis.
    Meng Q; Wang W; Liu X; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2018 Nov; 13(1):223. PubMed ID: 30453993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
    Matsuo K; Shimada M; Aoki Y; Sakamoto M; Takeshima N; Fujiwara H; Matsumoto T; Mikami M; Sugiyama T
    Int J Cancer; 2017 Sep; 141(5):1042-1051. PubMed ID: 28524247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases.
    Cheng X; Cai SM; Li ZT; Wu XH; Ding YQ; Wang XE; Zang RY
    Int J Gynecol Cancer; 2008; 18(4):779-84. PubMed ID: 17944922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.